Filing Details

Accession Number:
0001179110-18-008426
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-12 20:55:09
Reporting Period:
2018-06-11
Accepted Time:
2018-06-12 20:55:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1157601 Madrigal Pharmaceuticals Inc. MDGL Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1423898 Rebecca Taub C/O Madrigal Pharmaceuticals, Inc.
200 Barr Harbor Drive, Suite 400
West Conshohocken PA 19428
Chief Medical Officer, Evp R&D Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-11 73,526 $287.46 655,540 No 4 S Indirect By SQN, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By SQN, LLC
Footnotes
  1. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.